Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination.

Most existing studies characterizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cell responses are peptide based. This does not allow evaluation of whether tested peptides are processed and presented canonically. In this study, we use recombinant vaccinia virus (rVACV)-m...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Yin, Z, Chen, J-L, Lu, Y, Wang, B, Godfrey, L, Mentzer, AJ, Yao, X, Liu, G, Wellington, D, Zhao, Y, Wing, PAC, Dejnirattisa, W, Supasa, P, Liu, C, Hublitz, P, Beveridge, R, Waugh, C, Clark, S-A, Clark, K, Sopp, P, Rostron, T, Mongkolsapaya, J, Screaton, GR, Ogg, G, Ewer, K, Pollard, AJ, Gilbert, S, Knight, JC, Lambe, T, Smith, GL, Dong, T, Peng, Y
Formato:	Journal article
Idioma:	English
Publicado em:	Cell Press 2023

Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination.

Registros relacionados